OPC Pharmaceutical JSC (HOSE:OPC)
Vietnam · Delayed Price · Currency is VND 23,500
0.00 (0.00%)
At close: May 21, 2026
OPC Pharmaceutical JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 111,500 | 115,881 | 107,060 | 122,234 | 142,128 | 126,377 |
Depreciation & Amortization | 21,500 | 21,555 | 22,301 | 22,895 | 22,819 | 22,502 |
Other Amortization | 151.42 | 151.42 | - | - | - | - |
Loss (Gain) From Sale of Assets | -20,913 | -21,006 | -10,046 | -16,692 | -8,794 | -3,849 |
Other Operating Activities | -10,549 | -8,545 | -29,284 | -12,044 | -19,758 | -11,064 |
Change in Accounts Receivable | -103,074 | -53,039 | -24,493 | -65,383 | -38,502 | 9,687 |
Change in Inventory | -30,113 | -28,655 | -15,257 | 44,070 | 107,395 | 13,615 |
Change in Accounts Payable | 21,169 | 39,890 | -24,816 | 1,878 | -11,597 | 33,295 |
Change in Other Net Operating Assets | -1,890 | -6,303 | -1,739 | -797.68 | 1,597 | 159.36 |
Operating Cash Flow | -12,217 | 59,928 | 23,725 | 255,359 | 36,088 | 190,721 |
Operating Cash Flow Growth | - | 152.60% | -90.71% | 607.60% | -81.08% | 53.61% |
Capital Expenditures | -27,257 | -18,253 | -11,578 | -12,042 | -7,399 | -8,912 |
Sale of Property, Plant & Equipment | -906.67 | - | 175.97 | - | 182.59 | - |
Investment in Securities | -179,871 | -179,871 | -193,000 | 42,529 | -50,830 | 11,966 |
Other Investing Activities | 14,465 | 13,818 | 9,146 | 17,655 | 6,905 | 4,983 |
Investing Cash Flow | 21,530 | -13,107 | -46,487 | 48,142 | -51,142 | 8,037 |
Short-Term Debt Issued | - | - | - | 36,470 | 17,053 | 309,153 |
Total Debt Issued | -4,000 | - | - | 36,470 | 17,053 | 309,153 |
Short-Term Debt Repaid | - | - | - | -36,470 | -88,390 | -314,405 |
Total Debt Repaid | - | - | - | -36,470 | -88,390 | -314,405 |
Net Debt Issued (Repaid) | -4,000 | - | - | - | -71,337 | -5,252 |
Common Dividends Paid | -8.54 | - | -95,943 | -95,827 | -26,582 | -53,403 |
Financing Cash Flow | -4,009 | - | -95,943 | -95,827 | -97,919 | -58,655 |
Foreign Exchange Rate Adjustments | 23.68 | 10.13 | 25.3 | 8.98 | 0.03 | 23.66 |
Net Cash Flow | 5,328 | 46,832 | -118,680 | 207,683 | -112,973 | 140,127 |
Free Cash Flow | -39,475 | 41,675 | 12,147 | 243,317 | 28,688 | 181,809 |
Free Cash Flow Growth | - | 243.09% | -95.01% | 748.14% | -84.22% | 94.78% |
Free Cash Flow Margin | -3.50% | 3.71% | 1.25% | 24.21% | 2.45% | 16.18% |
Free Cash Flow Per Share | -616.30 | 650.66 | 189.65 | 3798.80 | 447.90 | 2838.51 |
Cash Interest Paid | - | - | - | 334.55 | 1,413 | 4,439 |
Cash Income Tax Paid | 33,160 | 29,802 | 28,021 | 35,982 | 37,622 | 37,198 |
Levered Free Cash Flow | -35,272 | 57,244 | 12,728 | 94,622 | 149,153 | 204,691 |
Unlevered Free Cash Flow | -35,272 | 57,244 | 12,728 | 94,831 | 149,731 | 207,703 |
Change in Working Capital | -113,908 | -48,108 | -66,306 | 138,966 | -100,307 | 56,756 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.